Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Kura Oncology Inc fell by 14.48m. Cash Flow from Financing totalled 94.78m or -- of revenues. In addition the company used 124.82m for operations while cash from investing totalled 15.56m.
Cash flow per share | -2.23 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.10 |
---|---|
Tangible book value per share | 6.10 |
More ▼
Balance sheet in USDView more
Current ratio | 14.94 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0202 |
---|---|
Total debt/total capital | 0.0198 |
More ▼